Fundz

Seneca Therapeutics, Inc. reported raising $501,000 in an initial SEC Form D filing, from an offering of $3.25 Million

PRIVATEJun 23, 2020$501K of $3.3M raised

Amount Raised

$501,000

$501,000 sold, per SEC Form D (first sale Jun 23, 2020)

Round Type

Seed

Blue BellHealthcareHealth Care

Quick answer

Seneca Therapeutics raised $501,000 in a Seed round, dated June 23, 2020. Seneca Therapeutics is based in Blue Bell, Pennsylvania, United States.

How much did Seneca Therapeutics raise?
Seneca Therapeutics raised $501,000 in a Seed round on June 23, 2020.
What does Seneca Therapeutics do?
Seneca Therapeutics was found by Dr. Paul Hallenbeck to develop the Seneca Valley Virus (“SVV-001”), a best in class oncolytic virus.
Where is Seneca Therapeutics based and how big is it?
Seneca Therapeutics is based in Blue Bell, Pennsylvania, United States. Fundz records about 10 employees.
Who are the decision-makers at Seneca Therapeutics?
Fundz holds 1 contact at Seneca Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Seneca Therapeutics, and when

A new round usually means Seneca Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Seneca Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Seneca Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Seneca Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Seneca Therapeutics

Location

Blue Bell, Pennsylvania, United States

About

Seneca Therapeutics was found by Dr. Paul Hallenbeck to develop the Seneca Valley Virus (“SVV-001”), a best in class oncolytic virus. SVV-001 is already in Phase I/II and has a clinical safety record in humans. SVV-001 binds to the TEM8 receptor which is common in many solid tumors like breast cancer, lung cancer and neuroendocrine tumors. SVV-001 is also being considered as a viral vector for gene therapy targeting the TEM8 receptor in solid tumors.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Seneca Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPaul H., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Seneca Therapeutics's next move

See what Strategic adds

Seneca Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.